mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes

Clinical trial NCT06919796 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06919796
Sponsor: PharmaJet, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Evaluate Immune Responses Following mRNA COVID-19 Vaccine Administration Through Different Delivery Routes in Healthy Volunteers SARS CoV-2

Start date: 2025-05-01
Primary completion: 2026-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.